Anavex Life Sciences Corp. / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €0.00
    Gross profit
    €0.00
    SG&A expenses
    €11.24M
    R&D expenses
    €36.06M
    EBITDA
    -€44.03M
    D&A
    €13.84M
    EBIT
    -€36.52M
    Interest expenses
    €0.00
    EBT
    -€32.43M
    Tax expenses
    -€571.21K
    Net income
    -€20.45M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €1.62M
    Changes in working capital
    -€564.31K
    Operating cash flow
    -€31.96M
    Capex
    €0.00
    Other investing cash flow
    €0.00
    Net investing cash flow
    €0.00
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €498.84K
    Debt repayment
    €0.00
    Other financing cash flow
    -€924.44K
    Net financing cash flow
    -€425.61K
    Foreign exchange effects
    €0.00
    Net change in cash
    -€32.39M
    Cash at end of period
    €87.16M
    Free cash flow
    -€31.96M

    Balance sheet

    Cash and cash equivalents
    €87.16M
    Cash and short-term investments
    €87.16M
    Total receivables
    €706.47K
    Inventory
    €0.00
    Other current assets
    -€706.47K
    Total current assets
    €87.16M
    Property, plant & equipment
    €0.00
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €0.00
    Total non-current assets
    €0.00
    Total assets
    €88.25M
    Accounts payable
    €5.81M
    Short-term debt
    €0.00
    Other current liabilities
    €0.00
    Total current liabilities
    €6.50M
    Long-term debt
    €0.00
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €3.39M
    Total non-current liabilities
    €3.39M
    Total liabilities
    €9.89M
    Common stock
    €73.23K
    Retained earnings
    -€321.03M
    Other equity
    €0.00
    Total equity
    €78.36M
    Total liabilities and shareholders' equity
    €88.25M

    Company information

    Market capitalization
    €690.31M
    Employees
    42
    Enterprise Value
    €584.28M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    -26.1% Even with peer group: -27.7%
    ROA
    -23.2% Much better than peer group: -242.3%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    -4.6%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    -€486.80K

    Notifications